5HX-40728-37879
4 vaccinations
3 coded responses
19 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 852 / AZ
- Registered
- 2022-02-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Dose 2 — Pfizer-BioNTech
-
2022-02-21
Dose 3 — Pfizer-BioNTech
-
2022-02-22
Registered in v-safe
- 2022-02-22
- 2022-02-23
- 2022-02-24
- 2022-02-25
-
2022-02-26
Survey response — days 1–6 daily, dose 3MedDRA: Granuloma annulare, Office visit — Feeling: Good · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): I've had disseminated granuloma annulare from the 2nd Pfizer shot 4/2/21. Might be seeing a bit of flare up, but it is not itchy or painful. · Healthcare visit (other): I have been under doctor's care for the GA rash. Have not needed to return following the booster this week.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-26
Report sent to call center — days 1–6 daily, dose 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-02-27
Survey response — days 1–6 daily, dose 3MedDRA: Granuloma annulare — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: ongoing (granuloma annulare), see previous reporting. No change.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-28
Survey response — day 7, dose 3MedDRA: Rash — Feeling: GoodFree text: I WOULD LIKE TO BE CONTACTED ABOUT MY RASH, WHICH I STILL HAVE FROM AFTER THE 2ND PFIZER SHOTMedDRA releases: 2024-11 · check-in free text available
- 2022-03-14
- 2022-03-22
- 2022-03-24
-
2022-03-25
Call successfulDoes not wish to fill out VAERS report
- 2022-03-30
- 2022-04-04
- 2022-08-24
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-10-04
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-12-17
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | No |
| 2 | 2021-04-02 | Pfizer-BioNTech | No |
| 3 | 2022-02-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): I've had disseminated granuloma annulare from the 2nd Pfizer shot 4/2/21. Might be seeing a bit of flare up, but it is not itchy or painful.
Healthcare visit (other): I have been under doctor's care for the GA rash. Have not needed to return following the booster this week.
Systemic reaction (other): ongoing (granuloma annulare), see previous reporting. No change.
Release 11 — day 7, dose 3
Systemic reaction (other): I WOULD LIKE TO BE CONTACTED ABOUT MY RASH, WHICH I STILL HAVE FROM AFTER THE 2ND PFIZER SHOT
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Granuloma annulare | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| SRO | Granuloma annulare | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release